Lobe Sciences Ltd.

C$0.04As of Sun 8 Nov 2026, 12:00 UTC
CSE:LOBEHealthcare
Country Canada
PE (Fwd) •••
TSR 7Y CAGR (38.19%)
Div yield —
ROE (214.20%)
Biotechnology
Beta (5Y) 0.16
PE TTM —
TSR TTM (11.11%)
Mkt cap C$13.58M
ROIC (91.21%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0401
0.16%
(74.91%)
Hold 10|11|4|9|6
1Q26
2Q26
3Q26
4Q26
Earnings per share$
—
—
—
—
24.37%
34.07%
34.10%
36.18%
Revenue$M
0.762
0.792
0.785
0.774
4.23%
6.77%
1.60%
2.35%
Peers (US$9.614M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
2.216
0.162
0.128
EBIT/Intx
1.717
0.360
0.367
Own earn%
47.52
(30.17)
(48.59)
Sh yield%
33.11
19.58
18.82
Owners
Insiders/Inst%
10.66
26.52
Short interest%
4.91
SBC / revenue%
4.04
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
8–15
$1 testx
—
Incr. ROIC%
11